Radiotherapy and radiology: Joint efforts for modern radiation planning and practice

Diagnostic and Interventional Imaging

Volumn 93, Issue 5, 2012, Pages 342-350

  Thariat, J ^a   Marcy, P Y ^a   Lacout, A ^b   Ramus, L ^c,d   Girinsky, T ^e   Pointreau, Y ^f   Malandain, G ^d  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b Medical Imaging Center   (France)

^c DOSIsoft SA   (France)

^d INRIA   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f CHU BRETONNEAU   (France)

Author keywords

Adaptive radiotherapy; Contouring; Imaging; Innovative radiation therapy; Variability

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL PRACTICE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; CYBERKNIFE; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NOMOGRAM; QUALITY CONTROL; RADIATION DOSE; RADIOLOGY; REVIEW; TREATMENT PLANNING; METHODOLOGY; RADIOGRAPHY;

HUMANS; RADIOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84868656486     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: 10.1016/j.diii.2012.02.004     Document Type: Short Survey

References (30)

1. Chavaudra J, Bridier A. Definition of volumes in external radiotherapy: ICRU reports 50 and 62. Cancer Radiother 2001;5(5):472-8.
2. Pointreau Y, Bera G, Barillot I. Help for delineation: what kind of tools? Cancer Radiother 2009;13(6-7):600-5.
3. Thariat J, Li G, Angellier G, Marchal S, Palamini G, Rucka G, et al. Current indications and ongoing clinical trials with CyberKnife stereotactic radiotherapy in France in 2009. Bull Cancer 2009;96(9):853-64.
4. Mortele KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 2005;184(1):31-4.
5. Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to i.v. non-ionic iodinated contrast material in children. AJR Am J Roentgenol 2007;188(6):1643-7.
6. Aspelin P. Nephrotoxicity and the role of contrast media. Radiat Med 2004;22(6):377-8.
7. Choyke PL, Cady J, DePollar SL, Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 1998;4(2):65-9.
8. Halvorsen RA. Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging. Radiology 2008;249(1):9-15.
9. Dhermain F. Dynamic and anatomic MRI in radiation therapy for gliomas. Bull Cancer 2010;97(7):753-8.
10. Swaminathan S, Horn TD, Pellowski D, Abul-Ezz S, Bornhorst JA, Viswamitra S, et al. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. N Engl J Med 2007;357(7):720-2.
11. Kantor G, Mahe MA, Giraud P, Alapetite C, Durdux C, Fourquet A, et al. French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins. Cancer Radiother 2007;11(6-7):331-7.
12. Saliou MG, Giraud P, Simon L, Fournier-Bidoz N, Fourquet A, Dendale R, et al. Radiotherapy for breast cancer: respiratory and set-up uncertainties. Cancer Radiother 2005;9(6-7):414-21.
13. Lawton CA, Michalski J, El-Naqa I, Kuban D, Lee WR, Rosenthal SA, et al. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009;74(2):377-82.
14. White EA, Brock KK, Jaffray DA, Catton CN. Inter-observer variability of prostate delineation on cone beam computerised tomography images. Clin Oncol (R Coll Radiol) 2009;21(1):32-8.
15. Hurkmans CW, Borger JH, Pieters BR, Russell NS, Jansen EP, Mijnheer BJ. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 2001;50(5):1366-72.
16. Petersen RP, Truong PT, Kader HA, Berthelet E, Lee JC, Hilts ML, et al. Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 2007;69(1):41-8.
17. Kepka L, Bujko K, Garmol D, Palucki J, Zolciak-Siwinska A, Guzel-Szczepiorkowska Z, et al. Delineation variation of lymph node stations for treatment planning in lung cancer radiotherapy. Radiother Oncol 2007;85(3):450-5.
18. Petric P, Dimopoulos J, Kirisits C, Berger D, Hudej R, Potter R. Inter-and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008;89(2):164-71.
19. Dimopoulos JC, De Vos V, Berger D, Petric P, Dumas I, Kirisits C, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2009;91(2):166-72.
20. Bekelman JE, Wolden S, Lee N. Head-and-neck target delineation among radiation oncology residents after a teaching intervention: a prospective, blinded pilot study. Int J Radiat Oncol Biol Phys 2009;73(2):416-23.
21. Dewas S, Vautravers-Dewas C, Blanchard P, Pointreau Y, Denis F, Lacornerie T, et al. Variabilité inter-radiothérapeutes de la délinéation tumorale en oncologie thoracique : exemple d'intercomparaison de contourages et impact de la formation. Cancer Radiother 2010;14(2):103-10.
22. Coles CE, Hoole AC, Harden SV, Burnet NG, Twyman N, Taylor RE, et al. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol. Radiother Oncol 2003;69(2):189-94.
23. Seddon B, Bidmead M, Wilson J, Khoo V, Dearnaley D. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. Radiother Oncol 2000;56(1):73-83.
24. Ramus L, Thariat J, Marcy PY, Pointreau Y, Bera G, Commowick O, et al. Outils de contourage, utilisation et construction d'atlas anatomiques: exemples des cancers de la tête et du cou. Cancer Radiother 2010;14(3):206-12.
25. Padovani L, Huchet A, Claude L, Bernier V, Quetin P, Mahe M, et al. Inter-clinician variability in making dosimetric decisions in pediatric treatment: a balance between efficacy and late effects. Radiother Oncol 2009;93(2):372-6.
26. Girinsky T, Ghalibafian M, Paumier A. Évolution et dilemmes dans les traitements du lymphome de Hodgkin. Cancer Radiother 2009;13(6-7):479-81.
27. Thariat J, Marcié S, Marcy PY, Trimaud R, Angellier G, Mammar H, et al. La radiothérapie stéréotaxique avec Cyberknife®: aspects pratiques et développements technologiques récents. Bull Cancer 2010;97(7):807-18.
28. Mazal A, Habrand J, Delacroix S, Datchary J, Dendale R, Desjardins L, et al. La protonthérapie: bases, indications et nouvelles technologies. Bull Cancer 2010;97(7): 831-46.
29. Lagrange J, De Crevoisier R. La radiothérapie guidée par l'image (IGRT). Bull Cancer 2010;97(7):857-65.
30. Schwartz D, Ang K, Chronowski G, Rosenthal DI, Sejpal SV, Shah SJ, et al. Prospective experience with CT-guided adaptive radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;75(3):S72 [Supplement 1].